HOTTEST PENNY STOCK PICKS

[ALERTS100%to10000%GAIN]

VIRA~~HUGE DD,NEW WEBSITE,LIVE INTERVIEW,CEO holds 600M SHARES,NEWS





VIRA~~per Transfer Agent as of july 10th 2014,


O/S 754,143,750 shares

Restricted 668,687,689 shares

Float 85,456,061





Transfer Agent
12528 South 1840 E.
Draper, UT 84020
801-571-8844




Kevin Buckman, 4719 Quail Lakes Drive #G319, Stockton, CA 95207
Dr. Buckman holds 600,000,000 common shares representing 79.6% of the issued and outstanding common shares
and 3,500,000 preferred shares, representing 90.1% of the issued and outstanding preferred shares






VIRA~~NEWS
Viratech and Newswire Sign Master Distribution and Syndication Agreement


Chris Ryan June 09, 2014

With Newswire's distribution, social networks built on Viratech's platform, are going to be able to leverage off their content in capturing increased contextual traffic, and a higher engagement" Stated Dr. Buckman CEO of Viratech.


(Newswire.net -- June 9, 2014) Stockton , California -- Viratech Corp (OTC: VIRA) and Newswire Network are proud to announce an agreement that allows unlimited content distribution and syndication for social networks built on the Viratech platform. The agreement allows all social networks that Viratech Corp. builds to have this broadcasting feature. This distribution and sydication enhancement allows Viratech to leverage the Newswire consolidated editorial review process. This process allows edited content to pass through the Newswire engine and be broad casted as authoritative content directly within the specific Viratech social network platform. This syndication delivers highly targeted contextual traffic, which has shown, leads to lower bounce rates, higher page views and increased time on the site.



"With Newswire's distribution, social networks built on Viratech's platform, are going to be able to leverage off their content in capturing increased contextual traffic, and a higher engagement" Stated Dr. Buckman CEO of Viratech.



DE Brown, Editor-in-Chief of Newswire, said “We are excited to team up with Viratech to publish their social networks original content. Leveraging the distribution resources of Newswire, we hope to be able to give a louder voice to the great stories generated by Viratech’s networks. Social networks that Viratech are creating are producing highly targeted and specific content. With our distribution agreement today, Newswire is going to broadcast this content, thus giving the members of Viratech developed social networks a louder voice to express themselves, which in turn will lead to higher level of engagement within the developed communities"



About Viratech


Viratech Social Network Platform
Viratech Social Network Platform




Viratech Corp. Viratech has leveraged its intellectual property suite in creating a turn key social network platform. These platforms are engineered for targeted niche communities, specifically in the medical and wellness space.



Additionally Viratech has created the first open source biotech research social network platform. The purpose of the platform is to make it possible for individuals or smaller companies to compete with larger companies in the race to protect new medicines or technology. This has been made possible by leveraging social collaboration in a way that allows new ventures the ability to protect their intellectual property, then simultaneously allowing those same ventures the ability to promote and produce their development



About Newswire

Newswire Network is an association of Independent Journalists. Through its website, www.newswire.net, member journalists are able to publish their content on the most popular News sites, that receive Newswire news through RSS feeds, or direct syndication. Newswire’s editorial staff maintains the integrity of its news stream, by reviewing and editing all submissions prior to publication. In addition, Newswire acts as a hub for original content generated on other websites through its API integration.

VIRA NEWS Investment Opportunities In Viratech's Biotech Social Network


Viratech Corp. (OTCPK:VIRA) has created the world's first open-source social networking platform focused specifically on healthcare issues, which allows its users (current patients, illness survivors, volunteer workers and other advocates) to interact and discuss the complexities of some of the world's most dangerous diseases. With the recent announcement of Cancer.im, Viratech is implementing social collaboration tools to construct what is likely to become the world's first experience-based healthcare search engine.

The Cancer.im format has some similarities to what is seen with Facebook (FB), Google's Google+ (GOOG) and LinkedIn (LNKD), but there are some key differences that separate Cancer.im from the pack. Viratech's innovative approach to social networking greatly builds on the work and utility of its competitors and creates some interesting long-term positioning opportunities for investors.


A New Take on Social Networking

Viratech's topic-specific Micro Social Networks (MSNs) mark a key innovation within the industry, providing spaces to collect important health content and promote these materials with news releases and platform updates which are given "authoritative status" in Google. In creating a virtual "Facebook for Cancer Patients," the process ensures higher-quality traffic will drive through the MSN, thus helping reduce advertising costs for the company. Viratech's efforts to promote and crowd-fund research and development in producing new technology are showing expansion as well. The most recent example can be found in the company's partnership with the Diabetes Network Charities, which will create a patient interactive platform for Diabetes patients.

Viratech's Innovative Revenue Models

For investors, an innovative industry product has limited value without a sound revenue model, and Viratech has structured its Cancer.im offering in ways that approach this task from a variety of directions. Cancer.im uses a unique revenue model that focuses on high-priced items sold through the MSN and are directed at a targeted audience. Costs typically associated with cancer treatments and medications are elevated when compared to items such as cellphones, digital media, and beauty products commonly sold to an internet consumer base.

The high-priced items and services in the healthcare industry (such as prescription drugs, insurance premiums, and symptom management) are associated with higher advertising costs, and Viratech will be in a position to strongly benefit from these trends. Marketing approaches on Cancer.im allow users to create advertising space on information pages that are most directly related to the products and services being offered, and the level of relevance in this space far surpasses what is available on other healthcare sites. For example, overseas clinics specializing in the treatment of Stage IV Breast Cancer could be featured on the Cancer.im social networking page which is dedicated to (and run by) Stage IV Breast Cancer patients. This level of specificity is simply not possible with most of the industry competition.

Capitalizing on Viratech's Targeted Specificity

Viratech's advertising model enables advertisers to select cost structures that are most appropriate for their products, which will likely increase competition for the available space that is offered on each page in the MSN. Users of healthcare networking sites are more inclined to be actively looking to purchase relevant products when compared to the "browsing mindset" of those using more traditional social networks. Viratech has the ability to leverage contextual ad placements for products that are both high-priced and essential, which puts the company in a position to profit from direct markets that cannot be easily accessed by most of its industry competition.

The combination of technological innovation (in an essential market) and sound revenue models (to drive future financial viability) creates a highly bullish scenario for Viratech and its subsidiaries. Recent moves to increase industry partnerships (gaining exposure to new areas such as Diabetes) suggest a growth-oriented approach at Viratech, and as long as the company maintains its innovative approach to broadcasting and content-building, the stock remains well-positioned for significant upside going forward.

http://www.gurufocus.com/news/266052/investment-opportunities-in-viratechs-biotech-social-network


http://viratech.org/article/category/view/feeditem_id/1

http://viratech.org/newsroom

http://cancer.im/newsroom


http://www.otcmarkets.com/financialReportViewer?symbol=VIRA&id=121600